Home » Topics » Disease categories and therapies » Immune

Immune
RSS

ShK5(L5) delays extravasation and reduces motility of effector memory T-cells

Feb. 5, 2007

FDA Advisory Committee date set for orBec review in GI GVHD

Feb. 2, 2007

Novel immunomodulatory agents imparted in recent Astellas patent

Jan. 30, 2007

Prograf approved in Japan for lupus nephritis

Jan. 30, 2007

Remicade approved in Japan for Behcet's disease with refractory uveoretinitis

Jan. 30, 2007

Pentacel recommended for approval

Jan. 30, 2007

Kirin and Astellas collaborate on anti-CD40 antagonistic MAb

Jan. 26, 2007

Cell Therapeutics makes unsolicited offer for DOR BioPharma

Jan. 26, 2007

FDA action letter received for immunosuppressant FK-506 MR

Jan. 25, 2007

Pivotal phase III grass allergy trial of Pollinex Quattro begins

Jan. 25, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...